MX2009007413A - Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos. - Google Patents

Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos.

Info

Publication number
MX2009007413A
MX2009007413A MX2009007413A MX2009007413A MX2009007413A MX 2009007413 A MX2009007413 A MX 2009007413A MX 2009007413 A MX2009007413 A MX 2009007413A MX 2009007413 A MX2009007413 A MX 2009007413A MX 2009007413 A MX2009007413 A MX 2009007413A
Authority
MX
Mexico
Prior art keywords
derivatives
quinolone
quinolone carboxylic
processes
preparation
Prior art date
Application number
MX2009007413A
Other languages
English (en)
Spanish (es)
Inventor
Arthur E Harms
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of MX2009007413A publication Critical patent/MX2009007413A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2009007413A 2007-01-24 2008-01-11 Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos. MX2009007413A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/626,397 US7632944B2 (en) 2007-01-24 2007-01-24 Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
PCT/US2008/050865 WO2008091752A2 (en) 2007-01-24 2008-01-11 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
MX2009007413A true MX2009007413A (es) 2009-07-17

Family

ID=39410211

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007413A MX2009007413A (es) 2007-01-24 2008-01-11 Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos.

Country Status (10)

Country Link
US (1) US7632944B2 (enExample)
EP (1) EP2114915A2 (enExample)
JP (1) JP2010516775A (enExample)
KR (1) KR20090118027A (enExample)
CN (1) CN101595101A (enExample)
AU (1) AU2008209416B2 (enExample)
BR (1) BRPI0806581A2 (enExample)
CA (2) CA2674543C (enExample)
MX (1) MX2009007413A (enExample)
WO (1) WO2008091752A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090054406A1 (en) * 2007-08-21 2009-02-26 Ward Keith W Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones
US8415342B2 (en) * 2008-10-29 2013-04-09 Bausch & Lomb Incorporated Besifloxacin ophthalmic composition for the treatment or control of infection
MY161597A (en) 2008-11-15 2017-04-28 Rib-X Pharmaceuticals Inc Antimicrobial compositions
US8481526B2 (en) * 2009-03-25 2013-07-09 Bausch & Lomb Incorporated Fluoroquinolone carboxylic acid molecular crystals
NL2004142C2 (nl) 2010-01-25 2011-07-26 Mci Mirror Controls Int Nl Bv Buitenspiegeleenheid, spiegeldrager, werkwijze voor montage van een buitenspiegeleenheid.
US10167271B2 (en) 2015-01-28 2019-01-01 Mankind Pharma Ltd Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride
CN111087390B (zh) * 2017-11-10 2022-07-05 西南大学 氟喹诺酮类胺基衍生物及其用途
CN112159355B (zh) * 2020-09-25 2022-06-24 西南大学 对氨基水杨酸氟喹诺酮类衍生物及其中间体、制备方法和应用
CN112159354B (zh) * 2020-09-25 2022-07-05 西南大学 对氨基水杨酸的氟喹诺酮类衍生物及其中间体、制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines
HU204512B (en) 1986-01-20 1992-01-28 Kyorin Seiyaku Kk New process for producing quinoline-carboxylic acid derivatives
JPS63132885A (ja) 1986-11-25 1988-06-04 Hokuriku Seiyaku Co Ltd キノリン−3−カルボン酸誘導体
JPS63196580A (ja) 1987-02-09 1988-08-15 Hokuriku Seiyaku Co Ltd キノリン−3−カルボン酸誘導体
JPS63196579A (ja) 1987-02-09 1988-08-15 Hokuriku Seiyaku Co Ltd キノリン−3−カルボン酸誘導体
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
TW222272B (enExample) 1992-05-26 1994-04-11 Ss Seiyaku Kk
US5527910A (en) 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
TW301607B (enExample) * 1993-03-09 1997-04-01 Takeda Pharm Industry Co Ltd
FR2706459B1 (fr) 1993-06-17 1995-08-04 Bouchara Sa Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
KR20000036104A (ko) * 1996-09-13 2000-06-26 둘락 노먼 씨. 파르네실-단백질 트랜스퍼라제의 억제제로서 유용한 신규한트리사이클릭 피페리디닐 화합물
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
JP4612301B2 (ja) * 2003-12-26 2011-01-12 広栄化学工業株式会社 1−アルキル−4−アミノメチルピペリジンの製造法
DE102004035203A1 (de) * 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone

Also Published As

Publication number Publication date
WO2008091752A2 (en) 2008-07-31
US7632944B2 (en) 2009-12-15
CA2674543C (en) 2012-12-04
AU2008209416B2 (en) 2013-05-09
JP2010516775A (ja) 2010-05-20
CA2790690A1 (en) 2008-07-31
AU2008209416A1 (en) 2008-07-31
CA2674543A1 (en) 2008-07-31
CN101595101A (zh) 2009-12-02
BRPI0806581A2 (pt) 2014-05-06
WO2008091752A3 (en) 2008-10-16
EP2114915A2 (en) 2009-11-11
KR20090118027A (ko) 2009-11-17
US20080176834A1 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
MX2009003313A (es) Acidos quinolona carboxilicos, derivados de los mismos, procesos para su preparacion y su uso como agentes antibacterianos.
MX2009007413A (es) Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos.
WO2012122340A8 (en) Soluble guanylate cyclase activators
GEP20217235B (en) Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
GEP20135919B (en) Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors
MX2010003155A (es) Derivados de ciclopropil aril amida y uso de los mismos.
EP4252848A3 (en) Oxysterols and methods of use thereof
EP4609866A3 (en) Oxysterols and methods of use thereof
EP4616908A3 (en) Oxysterols and methods of use thereof
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
MY173448A (en) Phenyl and benzodioxinly substituted indazoles derivatives
MX2011012122A (es) Derivados de tiofeno.
SG10201806565SA (en) Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
HK1255500A1 (zh) 氧固醇及其使用方法
WO2012004396A3 (en) Process of preparing a thrombin specific inhibitor
WO2011159124A3 (ko) Interleukin-6 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물
WO2017177004A8 (en) Tertiary amides and method of use
EP4477222A3 (en) Crystalline 4-(5-chloro-2-isopropylaminopyridin-4-yl)-1h-pyrrole-2-carboxylic acid [1-(3-chlorophenyl)-2-hydroxyethyl]amide hydrochloride salt
WO2007032028A8 (en) Thiazolinones and oxazolinones and their use as ptp1b inhibitors
WO2011008666A3 (en) 3-phenoxymethylpyrrolidine compounds
NZ591837A (en) Amino acid derivative
WO2010038948A3 (en) Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
WO2012022120A8 (zh) 二氢吡唑类化合物

Legal Events

Date Code Title Description
FG Grant or registration